NASDAQ:BMRN
BioMarin Pharmaceutical Inc. Stock News
$92.06
+2.57 (+2.87%)
At Close: Apr 23, 2024
Biotech stocks: Vertex looks bullish on ‘rapidly-growing CF business,' analyst says
03:49pm, Thursday, 05'th Jan 2023
Bank of America Global Research Sr. Pharma Analyst Geoff Meacham joins Yahoo Finance Live anchors Akiko Fujita and Rachelle Akuffo to discuss China's COVID-19 chaos, the pharma space, biotech stocks,
BioMarin's (BMRN) Voxzogo Expanded Label Filing Accepted by EMA
04:10pm, Wednesday, 04'th Jan 2023 Zacks Investment Research
The EMA validates BioMarin's (BMRN) label expansion filing for Voxzogo to treat children under two years with achondroplasia. BMRN submits a filing for using Voxzogo in children under five years.
BioMarin's (BMRN) Voxzogo Expanded Label Filing Accepted by EMA
12:47pm, Wednesday, 04'th Jan 2023
The EMA validates BioMarin's (BMRN) label expansion filing for Voxzogo to treat children under two years with achondroplasia. BMRN submits a filing for using Voxzogo in children under five years.
FDA Approval, Top Funds Lift Drugmaker In Ailing Market
08:05am, Thursday, 29'th Dec 2022
Boosted by demand among the best mutual funds and an FDA approval, AbbVie shows strength in ailing market. The post FDA Approval, Top Funds Lift Drugmaker In Ailing Market appeared first on Investor's
Biotech Stock Finds Favor Amongst Mutual Fund Managers
10:09am, Friday, 23'rd Dec 2022
A hyper-bullish breakaway gap supports positive price action in this leading biotech stock. The post Biotech Stock Finds Favor Amongst Mutual Fund Managers appeared first on Investor's Business Daily.
BioMarin Pharmaceutical - Solutions For Rare Illnesses
11:52pm, Friday, 16'th Dec 2022
100% technical buy signals. 13 new highs and up 26.03% in the last month.
Biotech Hasn't Been This Blazing Hot Since Early 2021 — Here Are The Top 5
12:24pm, Wednesday, 14'th Dec 2022
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
Netflix, Workday, Costco, Caterpillar and more: These stocks are Cowen's favorites for 2023
12:57pm, Monday, 12'th Dec 2022 MarketWatch
Across the market, Cowen & Co. analysts see undervalued stocks.
Why Is Horizon Therapeutics (HZNP) Up 38.3% Since Last Earnings Report?
04:31pm, Friday, 02'nd Dec 2022 Zacks Investment Research
Horizon Therapeutics (HZNP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Incyte (INCY) Up 3.3% Since Last Earnings Report: Can It Continue?
04:31pm, Thursday, 01'st Dec 2022 Zacks Investment Research
Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Expert Ratings for Biomarin Pharmaceutical
06:03pm, Tuesday, 29'th Nov 2022 Benzinga
Analysts have provided the following ratings for Biomarin Pharmaceutical (NASDAQ:BMRN) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
5
Why Is BioMarin (BMRN) Up 14.1% Since Last Earnings Report?
04:31pm, Friday, 25'th Nov 2022 Zacks Investment Research
BioMarin (BMRN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Biotech Stock BioMarin Scores Breakout After FDA Announcement
01:52pm, Friday, 25'th Nov 2022
BioMarin broke out after the FDA said it wouldn't hold an advisory committee meeting on its hemophilia A gene therapy. The post Biotech Stock BioMarin Scores Breakout After FDA Announcement appeared f
BioMarin (BMRN) Up After FDA Scraps AdCom Meet for BLA Filing
04:25pm, Thursday, 24'th Nov 2022 Zacks Investment Research
The FDA decides not to hold an advisory committee meeting for BioMarin Pharmaceuticals' (BMRN) regulatory filing seeking approval for hemophilia A gene therapy, valrox.
BioMarin (BMRN) Up After FDA Scraps AdCom Meet for BLA Filing
12:47pm, Thursday, 24'th Nov 2022
The FDA decides not to hold an advisory committee meeting for BioMarin Pharmaceuticals' (BMRN) regulatory filing seeking approval for hemophilia A gene therapy, valrox.
